Neurologic events in patients with atrial fibrillation: Outcome and prevention practices;Neurologische ereignisse bei patienten mit vorhofflimmern: Outcome und präventionspraxis

Zeitschrift fur Kardiologie

Volumn 89, Issue 12, 2000, Pages 1090-1097

  Carlsson, J ^a   Miketic, S ^a   Flicker, E ^a   Erdogan, A ^a   Haun, S ^a   Cuneo, A ^a   Tebbe, U ^a  

^a KERCKHOFF HEART CENTER   (Germany)

Author keywords

Atrial fibrillation; Outcome; Prevention; Stroke; Transient ischemic attack

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; PHENPROCOUMON; TICLOPIDINE;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; TRANSIENT ISCHEMIC ATTACK;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0034510157     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003920070136     Document Type: Article

References (32)

1. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals
2. Predicting survival for 1 year among different subtypes of stroke. Results from the perth community stroke study
3. Causes and severity of ischemic stroke in patients with internal carotid artery stenosis
4. Warfarin use following ischemic stroke among medicare patients with atrial fibrillation
5. Mortality in acute stroke with atrial fibrillation
6. Multiple potential risks for stroke
7. Stroke prevention practices in patients with atrial fibrillation and pacemaker therapy: Evidence for underuse of anticoagulation
8. Prognostic factors in first-ever stroke in the carotid artery territory seen within 6 hours after onset
9. Report on cardiogenic brain embolism
10. Stroke and atrial fibrillation: Is stroke prevention treatment appropriate before-hand?
11. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke
12. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications
13. Underutilization of antithrombotic therapy in elderly rural patients with atrial fibrillation
14. Atrial fibrillation and stroke prevention with warfarin in the long-term care setting
15. Pathogenetic mechanism of stroke in non-valvular atrial fibrillation: Follow-up of stroke patients with and without atrial fibrillation
16. The European stroke scale
17. The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischemic stroke
18. Acute stroke with atrial fibrillation
19. Atrial fibrillation and stroke. Mortality and causes of death after the first acute ischemic stroke
20. The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the Manitoba follow-up study
21. Antithrombotic therapy in atrial fibrillation
22. Stroke severity in atrial fibrillation. The Framingham study
23. Treatment of ischemic stroke
24. Thromboembolism prophylaxis in chronic atrial fibrillation. Practice patterns in community and tertiary-care hospitals
25. Physicians attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly
26. Impact of long-term ECG recording on the detection of paroxysmal atrial fibrillation in patients after an acute ischemic stroke
27. Recent national patterns of warfarin use in atrial fibrillation
28. Für die CORSurvey-erhebung. Antithrombotische therapie bei vorhofflimmern und zusätzlichen schlaganfall-/embolie-risikofaktoren
29. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community
30. Duration of atrial fibrillation and imminence of stroke: The Framingham study
31. Atrial fibrillation as an independent risk factor for stroke: The Framingham study
32. Impact of atrial fibrillation on mortality, stroke, and medical costs